These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 602945)
1. Changes in distribution of platelet membrane glycoproteins in patients with myeloproliferative disorders. Bolin RB; Okumura T; Jamieson GA Am J Hematol; 1977; 3():63-71. PubMed ID: 602945 [TBL] [Abstract][Full Text] [Related]
2. Platelet membrane glycoprotein abnormalities in myeloproliferative disease. Greaves M; Pickering C; Gugliotta L; Preston FE Br J Haematol; 1986 Apr; 62(4):780-2. PubMed ID: 3964566 [No Abstract] [Full Text] [Related]
3. Platelets in myeloproliferative disorders. III: Glycoprotein profile in relation to platelet function and platelet density. Eche N; Sie P; Caranobe C; Nouvel C; Pris J; Boneu B Scand J Haematol; 1981 Feb; 26(2):123-9. PubMed ID: 7256210 [TBL] [Abstract][Full Text] [Related]
4. Abnormal aggregation and increased size of platelets in myeloproliferative disorders. Cortelazzo S; Barbui T; Bassan R; Dini E Thromb Haemost; 1980 Jun; 43(2):127-30. PubMed ID: 7455970 [TBL] [Abstract][Full Text] [Related]
8. Template bleeding time and clinical hemorrhage in myeloproliferative disease. Murphy S; Davis JL; Walsh PN; Gardner FH Arch Intern Med; 1978 Aug; 138(8):1251-3. PubMed ID: 277084 [TBL] [Abstract][Full Text] [Related]
9. Platelet unresponsiveness to collagen: involvement of glycoprotein Ia-IIa (alpha 2 beta 1 integrin) deficiency associated with a myeloproliferative disorder. Handa M; Watanabe K; Kawai Y; Kamata T; Koyama T; Nagai H; Ikeda Y Thromb Haemost; 1995 Mar; 73(3):521-8. PubMed ID: 7667837 [TBL] [Abstract][Full Text] [Related]
10. [Blood platelet function in chronic myeloid-type diseases. I. Myeloproliferative diseases]. Cieslar P; Matousová O Vnitr Lek; 1987 Nov; 33(11):998-1009. PubMed ID: 3439041 [No Abstract] [Full Text] [Related]
11. Blood platelet calcium content and aggregation behaviour in myeloproliferative disorders and secondary thrombocytosis. Mindner K; Ostermann G; Hochhaus A; Höche D; Till U Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(4):461-4. PubMed ID: 2465953 [TBL] [Abstract][Full Text] [Related]
12. Functional significance of the platelet alpha2-adrenoceptor: studies in patients with myeloproliferative disorders. Swart SS; Pearson D; Wood JK; Barnett DB Thromb Res; 1984 Mar; 33(5):531-41. PubMed ID: 6326344 [TBL] [Abstract][Full Text] [Related]
13. Platelet function studies in myeloproliferative disorders. Pfliegler G; Boda Z; Udvardy M; Kiss A; Telek B; Pecze K; Nagy P; Rak K Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(5):655-62. PubMed ID: 2435631 [TBL] [Abstract][Full Text] [Related]